Q3 2018 Holdings
Filed 2018-10-05 | 10 holdings | $294.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $160.1M | 3,608,874 | 54.4% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $47.7M | 1,204,615 | 16.2% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $34.5M | 3,616,221 | 11.7% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $15.2M | 2,215,384 | 5.2% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $12.0M | 1,084,696 | 4.1% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $8.5M | 4,492,975 | 2.9% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $7.6M | 2,208,210 | 2.6% |
| Achaogen, Inc. | Common Stock | 004449104 | $5.1M | 1,281,152 | 1.7% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $3.0M | 101,855 | 1.0% |
| OpGen, Inc. | Common Stock | 68373L109 | $207.4K | 102,167 | 0.1% |